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Summary
To test the hypothesis that myocardial hyper- intensities
on T2 weighted imaging in patients with hypertrophic
cardiomyopathy (HCM) reflect ongoing myocardial
injury, the cardiac- specific biomarker troponin T was
measured by a new highly sensitive assay (hs-cTnT). In
52 patients with HCM, the presence and extent of myo-
cardial T2 abnormalities were associated with hs-cTnT
levels. The number of LV segments with T2 hyper-inte-
sity was the strongest independent predictor of hs-cTnT
levels. This novel finding suggests that T2 imaging may
aid in the identification of HCM patients with active
and potentially progressive disease.
Background
In a sub-group of patients with hypertrophic cardiomyo-
pathy (HCM) abnormalities on T2 weighted imaging on
cardiovascular magnetic resonance imaging (CMR) have
been reported. The significance of this finding is still
not clear, although it has been proposed to reflect
ongoing myocardial injury. The loss of cardiomyocyte
cell integrity leads to the release of troponins into the
circulation. Recently, a highly sensitive cardiac troponin
T assay (hs-cTnT) was introduced which allows the
detection and quantification of very low serum levels of
cTnT with a high diagnostic accuracy.
We therefore aimed to test the hypothesis that the
presence and extent of myocardium with increased sig-
nal intensity on T2-weighted images in patients with
HCM is associated with evidence of cardiomyocyte
injury as assessed by the hs-cTnT assay.
Methods
The study cohort consists of 52 patients undergoing late
gadolinium enhanced CMR (LGE-CMR) on a 1.5T clini-
cal scanner (Philips Intera Achieva
®) for characterization
of hypertrophic cardiomyopathy in whom hs-cTnT was
measured by the ELECSYS
® a s s a y( R o c h eD i a g n o s t i c s ) .
Left ventricular (LV) volumes and mass were derived
from SSFP images. The presence of hyper-intense areas
on T2 images was assessed in the modified LV AHA-16
segment model by two blinded observers. LGE was
quantified in percent of LV mass.
Results
T2 hyper-intensities were present in 31 (60%) patients
(T2-pos) with a mean of 2.67± 1.6 LV-segments
affected. The presence of T2 hyper-intensity was asso-
ciated with increased septal wall thickness (12± 4.9 mm
vs. 16.9± 3.6 mm, p=0.05) and the presence (100% vs.
44.4%, p < 0.001) and extent of LGE (2.7± 5.9 % vs. 15.8
± 14.9 %, p=0.002). T2-pos patients showed markedly
increased levels of hs-cTnT (20.2± 16.4 pg/ml vs. 9.8±
7.5 pg/ml, p=0.02). Furthermore, the number of myocar-
dial segments showing a signal hyper-intensity on T2
imaging was correlated to hs-cTnT levels (R=0.52,
p=0.02). Remarkably, when entered into a multivariate
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was the only independent predictor of hs-cTnT levels in
addition to renal function (table1).
Conclusions
The presence and the extent of myocardial T2 abnorm-
alities in patients with HCM predict serum levels of hs-
cTnT and thus seem to reflect ongoing myocardial
damage. Whether this finding is associated with an
increased risk for future adverse events needs to be
examined in further studies.
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Table 1 Predictors of continuous hs-cTnT levels
B 95% CI of B p r
2
Univariate
Age (per year) 0.26 0.2-0.32 0.001 0.58
CAD 26.2 11.1-41.2 0.001 0.54
Creatinin (per mg/dl) 15.3 11.6-19.4 < 0.001 0.76
LV-EF (per %) 0.21 0.14-0.27 < 0.001 0.67
LV-T2 (per segment) 7 5-8.9 < 0.001 0.76
LGE volume (per %) 0.84 0.58-1.1 < 0.001 0.7
Multivariate
*
LV-T2 (per segment) 4.7 1.8-7.5 0.0003 0.87
creatinin 12.3 4.8-19.8 0.002
CAD:coronary artery disease; LV: left ventricular; EF: ejection fraction;LGE: late
gadolinium enhancement
* the multivariate model contains all listed univariate variables
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